SEC Form 4 · accession 0001209191-17-025759
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard S Jacob
Director
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2017 | M | 20,000 | $1.65 | A | 238,885 | D | |
| Common Stock | Apr 3, 2017 | S | 20,000 | $2.8785 | D | 218,885 | D | |
| Common Stock | Apr 4, 2017 | M | 21,762 | $1.65 | A | 240,647 | D | |
| Common Stock | Apr 4, 2017 | S | 21,762 | $2.9001 | D | 218,885 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.65 | Apr 3, 2017 | M | 20,000 | D | — | May 10, 2017 | Common Stock | 20,000 | 21,762 | D |
| Stock Option (right to buy)F2 | $1.65 | Apr 4, 2017 | M | 21,762 | D | — | May 10, 2017 | Common Stock | 21,762 | 0 | D |
Explanation of responses
- F1The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The exercised stock option reported on this Form 4 was due to expire on May 10, 2017.
- F2The options vested and became exercisable in four equal quarterly installments following the grant date of May 10, 2007.